Federal Court Overturns Gilead Sciences and Merck Patent Dispute Post author:Sam Post published:February 19, 2018 Post category:BioPharma Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision. Source: BioSpace You Might Also Like Consolidation Could Be Coming to Pharma Industry March 14, 2018 Amgen Jumps as Migraine Drug Wows in Late-Stage Study January 22, 2018 BioSig Technologies Release: Company Issues Shareholder Letter January 19, 2017